research use only

Azoramide PERK modulator

Cat.No.S8304

Azoramide is a small-molecule modulator of the unfolded protein response (UPR). It improves ER protein-folding ability and activates ER chaperone capacity to protect cells against ER stress.
Azoramide PERK modulator Chemical Structure

Chemical Structure

Molecular Weight: 308.83

Quality Control

Batch: S830401 DMSO]61 mg/mL]false]Ethanol]61 mg/mL]false]Water]Insoluble]false Purity: 99.59%
99.59

Chemical Information, Storage & Stability

Molecular Weight 308.83 Formula

C15H17ClN2OS

Storage (From the date of receipt)
CAS No. 932986-18-0 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CCCC(=O)NCCC1=CSC(=N1)C2=CC=C(C=C2)Cl

Solubility

In vitro
Batch:

DMSO : 61 mg/mL ( (197.51 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 61 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
UPR [1]
In vitro
Azoramide may have the protective effects of enhancing chaperone expression and reducing protein synthesis without inducing cytotoxicity and apoptosis. This compound may require the presence of intact IRE1 and PERK branches of the UPR to fully increase chaperone capacity. It is found to be a kind of compound with the dual property of not only boosting ER folding acutely but also activating ER chaperone capacity chronically to promote ER homeostasis. Its treatment potently protects cells against chemically-induced ER stress conditions. This chemical preserves beta cell function and survival during metabolic ER stress. Its pretreatment does not impair ER function as part of its initial action. This treatment leads to increased SERCA expression, resulting in enhanced retention of Ca+2 within the ER. It interacts with UPR pathways to promote resolution of ER stress and improve ER function[1].
In vivo
Azoramide improves glucose homeostasis in mice with genetic obesity and diet-induced obesity. Remarkably, this compound treatment significantly improves insulin sensitivity and glucose tolerance and beta cell function in obese mice in multiple preclinical models[1].
References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.